Rodon, P., Hulin, C., Pegourie, B., Tiab, M., Anglaret, B., Benboubker, L., . . . Moreau, P. (2015). Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: The Intergroupe Francophone du Myelome 2009-01 trial. Haematologica.
Trích dẫn kiểu ChicagoRodon, Philippe, et al. "Phase II Study of Bendamustine, Bortezomib and Dexamethasone As Second-line Treatment for Elderly Patients With Multiple Myeloma: The Intergroupe Francophone Du Myelome 2009-01 Trial." Haematologica 2015.
Trích dẫn MLARodon, Philippe, et al. "Phase II Study of Bendamustine, Bortezomib and Dexamethasone As Second-line Treatment for Elderly Patients With Multiple Myeloma: The Intergroupe Francophone Du Myelome 2009-01 Trial." Haematologica 2015.